Omada Health (OMDA) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Omada Health (OMDA) has outperformed GeneDx (WGS) over the past year, losing 10.3% versus a loss of 43.3%. GeneDx is the larger company by market cap ($2.04 billion vs $1.28 billion), about 1.6 times the size. On valuation, Omada Health trades at a lower forward P/E (37.6x vs 57.2x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | WGS |
|---|---|---|
| Share price | $20.89 | $68.53 |
| Market cap | $1.28B | $2.04B |
| 1-day change | +0.77% | -4.18% |
| YTD return | +32.38% | -47.31% |
| 1-year return | -10.34% | -43.25% |
| 5-year return | — | -73.34% |
| P/E ratio (TTM) | 87.04 | — |
| Forward P/E | 37.56 | 57.18 |
| EPS (TTM) | $0.24 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.92 | $170.87 |
| 52-week low | $10.28 | $32.21 |
| Distance from 52-week high | -22.39% | -59.89% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +36.05% | +36.44% |
| Average volume | 1.38M | 729.57K |
| Shares outstanding | 61.22M | 29.82M |
| Employees | 946 | 1,300 |
| Sector | Healthcare | Health Care |
| Industry | Health Information Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OMDA has outperformed WGS by 32.9 percentage points over the past year.
- The two companies sit in different sectors: Omada Health in Healthcare and GeneDx in Health Care.
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Healthcare · Health Information Services · 946 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
OMDA vs WGS FAQ
Which is bigger, Omada Health or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $2.04B compared with $1.28B for Omada Health (OMDA).
Which stock has performed better over the past year, OMDA or WGS?
OMDA returned -10.34% over the past 12 months, compared with -43.25% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are Omada Health and GeneDx in the same industry?
No. Omada Health is in the Healthcare sector, while GeneDx is in Health Care.